RKB Bioenergi A/S: Financial statements 2023
CVR: 43142070
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
RKB Bioenergi A/S (CVR 43142070) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -94,491 and a net result of DKK -82,533. Equity in the 2023 report amounted to DKK 1,994,207. The solvency ratio was 99.5%.
- Gross Profit
- DKK -94,491
- Profit/Loss
- DKK -82,533
- Equity
- DKK 1,994,207
- Total Assets
- DKK 2,004,207
- Employees
- 0
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of October 23, 2023, Frands Lunde Larsen has joined the board of directors of RKB Bioenergi A/S.
As of October 23, 2023, Hans Christian Tylvad has left the board of directors of RKB Bioenergi A/S.
As of September 26, 2023, Thomas Hedegaard has joined the board of directors of RKB Bioenergi A/S.
As of September 26, 2023, Lasse Nielsen has left the board of directors of RKB Bioenergi A/S.
RKB Bioenergi A/S has published its interim report for the period March 16, 2022 to December 31, 2022.
About RKB Bioenergi A/S
RKB Bioenergi A/S is a Danish company of the type Aktieselskab based in Ringkøbing, founded in 2022. The company is registered under the industry Produktion af gas. The management consists of Kim Gohr Nielsen. The board consists of Thomas Hedegaard (chair), Allan Skovbo Mikkelsen, Frands Lunde Larsen and Kim Gohr Nielsen. The company is owned by DBC Invest A/S and RKB Bioinvest A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -140,652 and a net result of DKK -109,565 compared with DKK -40,074 the year before. Equity in the 2025 report amounted to DKK 7,444,568.
